Saturday 17 October 2026
Export IH’s income statement to Excel — free account
iHuman Inc. Sponsored ADR
IH Consumer Defensive Education & Training Services
iHuman Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $115.4 million, down 8.66% from fiscal 2024. In the quarter to June 2026, revenue fell 8.55%, EPS fell 156.1% and free cash flow grew 613.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
1.16
0.02
+1.75%
Follow IH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
23.53 | 8.55 | 8.08 | 9.97 |
+8 more quarters Free account |
P/S ratio |
0.65 | 0.77 | 0.94 | 1.28 | |
P/FCF ratio |
1.13 | 1.38 | 1.70 | 2.57 | |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | |
P/B ratio |
0.58 | 0.63 | 0.76 | 1.07 | |
Price to Tangible BV |
0.59 | 0.64 | 0.77 | 1.09 | |
EV/Sales |
(0.70) | (0.64) | (0.49) | (0.09) | |
EV/EBITDA |
113.27 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.15) | (1.08) | (0.85) | (0.16) | |
EV/FCF |
(1.21) | (1.14) | (0.89) | (0.18) | |
Quick Ratio |
2.60 | 3.21 | 3.30 | 3.18 | |
Current Ratio |
2.91 | 3.50 | 3.57 | 3.46 | |
Net Debt/EBITDA |
48.47 | 108.99 | (109.30) | (67.69) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.60 | 0.59 | 0.59 | 0.59 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
— | — | (0.63) | — | |
Research and Development Expense of Revenue |
32.52% | 30.96% | 23.79% | 26.87% | |
Selling, General and Administrative Expense of Revenue |
43.61% | 41.40% | 38.06% | 33.37% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
1.58 | 1.48 | 1.23 | 0.87 | |
Graham Number |
1.79 | 3.50 | 4.02 | 4.20 | |
Earnings Yield |
4.25% | 11.70% | 12.38% | 10.03% | |
Free Cash Flow Yield |
88.51% | 72.48% | 58.69% | 38.95% | |
Revenue per Share |
0.50 | 0.52 | 0.58 | 0.56 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
2.90 | 3.12 | 3.20 | 3.10 | |
Shareholders Equity per Share |
2.40 | 2.72 | 2.77 | 2.70 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.40 | 2.72 | 2.77 | 2.70 | |
Free Cash Flow |
— | — | 6.64 | — | |
Working Capital |
114.10 | 130.33 | 133.62 | 129.70 | |
Capital Expenditures |
— | — | (0.70) | — | |
Net Current Asset Value |
113.13 | 129.06 | 132.30 | 128.35 | |
EV/EBIT |
113.27 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 17.12 | 11.31 | 14.90 | |
| Other line items | |||||
Average Receivables |
7.36 | 8.18 | 7.38 | 9.49 | |
Average Payables |
2.85 | 3.72 | 3.86 | 3.73 | |
Average Inventory |
3.90 | 3.32 | 3.14 | 2.64 | |
Average Assets |
184.81 | 190.76 | 195.08 | 197.30 | |
Average Common Equity |
128.96 | 134.35 | 136.97 | 135.06 |
Columns are period end dates · fundamentals updated 1 Oct 2026